Ascitic complement system in ovarian cancer

por Bjørge, L, Hakulinen, J, Vintermyr, O K, Jarva, H, Jensen, T S, Iversen, O E, Meri, S
Publicado 2005

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells

por Junnikkala, S, Hakulinen, J, Jarva, H, Manuelian, T, Bjørge, L, Bützow, R, Zipfel, P F, Meri, S
Publicado 2002

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas

por Haldorsen, I S, Stefansson, I, Grüner, R, Husby, J A, Magnussen, I J, Werner, H M J, Salvesen, Ø O, Bjørge, L, Trovik, J, Taxt, T, Akslen, L A, Salvesen, H B
Publicado 2014

STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trøndelag Health Study

por Fenstad, M.H., Johnson, M.P., Løset, M., Mundal, S.B., Roten, L.T., Eide, I.P., Bjørge, L., Sande, R.K., Johansson, Å.K., Dyer, T.D., Forsmo, S., Blangero, J., Moses, E.K., Austgulen, R.
Publicado 2010